(Q33897070)

English

A phase I and pharmacodynamic study of AT9283, a small-molecule inhibitor of aurora kinases in patients with relapsed/refractory leukemia or myelofibrosis

scientific article

Statements

A phase I and pharmacodynamic study of AT9283, a small-molecule inhibitor of aurora kinases in patients with relapsed/refractory leukemia or myelofibrosis (English)
14 November 2013

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit